|
National Drug Abuse Treatment |
![]() |
|
|
| PROTOCOL NIDA-CTN-0007b | ||||||||||||||||||||||||||||||||||||
This ancillary study is related to CTN-0004, "Motivational Enhancement Treatment to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse," CTN-0005, "Motivational Interviewing to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse," and CTN-0007, "Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics." It involves three cost-effectiveness analyses (CEAs) of treatment for substance abuse. Researchers will analyze the: 1) CTN trial of Motivational Enhancement Therapy Interviewing (Dr. Carroll, Principal Investigator); 2) CTN trial of Motivational Enhancement Therapy Intervention (Dr. Carroll, Principal Investigator); and 3) the CTN trial of Motivational Incentives (Dr. Stitzer, Principal Investigator). While there are well-known guidelines for CEA in general, there are important differences in applying CEA to drug treatment. At the culmination of these analyses, there will be findings on the cost-effectiveness of new therapies that will be useful for policy decisions and to build a database of CEAs of treatment programs.
|
|
|||||||||||||||||||||||||||||||||||
|
||